Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease? 2. Epidemiological data (Q30802266)

26 June 2017

1 reference

title

Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease? 2. Epidemiological data (English)

1 reference

26 June 2017

0 references

1 reference

Guilland JC

1

1 reference

26 June 2017

Favier A

2

1 reference

26 June 2017

Potier de Courcy G

3

1 reference

26 June 2017

Galan P

4

1 reference

26 June 2017

Hercberg S

5

1 reference

26 June 2017

1 March 2003

1 reference

26 June 2017

Pathology and Biology

1 reference

26 June 2017

51

1 reference

26 June 2017

2

1 reference

26 June 2017

111-121

1 reference

The controversy over homocysteine and cardiovascular risk

26 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Homocysteine and cardiovascular disease: cause or effect?

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Roles of homocysteine in cell metabolism: old and new functions.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Plasma total homocysteine concentration and the risk of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Studytpdel

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Metabolic Abnormalities Detected in a Survey of Mentally Backward Individuals in Northern Ireland

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

HOMOCYSTINURIA: AN ENZYMATIC DEFECT.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Cerebral thrombosis in a patient with homocystinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

The natural history of vascular disease in homocystinuria and the effects of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Homocystinuria due to cystathionine beta-synthase deficiency in Ireland: 25 years' experience of a newborn screened and treated population with reference to clinical outcome and biochemical control

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Thrombophilia, homocystinuria, and mutation of the factor V gene

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Plasma homocyst(e)ine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Plasma homocysteine and cardiovascular disease mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

The pathogenesis of coronary artery disease. A possible role for methionine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Hyperhomocysteinemia: an independent risk factor for vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Impaired homocysteine metabolism: a risk factor in young adults with atherosclerotic arterial occlusive disease of the leg

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Homocysteine and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Plasma homocyst(e)ine levels in men with premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

A prospective study of plasma homocyst(e)ine and risk of ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudication

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50--effect of smoking and extent of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

High homocysteine levels are independently related to isolated systolic hypertension in older adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Serum total homocysteine and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Elevated homocysteine levels are associated with increased ischemic myocardial injury in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Serum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Hyperhomocysteinaemia is not associated with isolated crural arterial occlusive disease: The Hoorn Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Homocysteine and risk of cardiovascular disease among postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Serum total homocysteine and coronary heart disease: prospective study in middle aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Homocysteine, a risk factor for coronary artery disease or not? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Homocysteine, vitamins B6, B12, folate, and risk of coronary artery disease in patients undergoing diagnostic coronary angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Thermolabile methylenetetrahydrofolate reductase in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

A common mutation in the methylenetetrahydrofolate reductase gene and risk of coronary heart disease: results among U.S. men.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Methylene tetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in a population with low plasma folate.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

The TT genotype of the methylenetetrahydrofolate reductase C677T gene polymorphism is associated with the extent of coronary atherosclerosis in patients at high risk for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

The methylenetetrahydrofolate reductase gene is associated with increased cardiovascular risk in Japan, but not in other populations

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Additional genetic risk factors for venous thromboembolism in carriers of the factor V Leiden mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Effect of the MTHFRC677T variant on risk of venous thromboembolism: interaction with factor V Leiden and prothrombin (F2G20210A) mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Opposite effects of plasma homocysteine and the methylenetetrahydrofolate reductase C677T mutation on carotid artery geometry in asymptomatic adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Vitamins and progression of atherosclerosis in hyper-homocyst(e)inaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with premature arterial disease and their relatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature peripheral arterial occlusive disease. A prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Decreased rate of coronary restenosis after lowering of plasma homocysteine levels

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Vascular disease and homocysteine metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Plasma homocysteine levels in patients with deep venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0369-8114%2803%2900105-6

7 January 2021

10.1016/S0369-8114(03)00105-6

Identifiers

DOI

1 reference

26 June 2017

1 reference